BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27513655)

  • 1. Potential beneficial effect of some adipokines positively correlated with the adipose tissue content on the cardiovascular system.
    Sawicka M; Janowska J; Chudek J
    Int J Cardiol; 2016 Nov; 222():581-589. PubMed ID: 27513655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines and the cardiovascular system: mechanisms mediating health and disease.
    Northcott JM; Yeganeh A; Taylor CG; Zahradka P; Wigle JT
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1029-59. PubMed ID: 22646022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of cardiovascular function by adipokines.
    DeClercq V; Enns JE; Yeganeh A; Taylor CG; Zahradka P
    Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):59-72. PubMed ID: 22882074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of adipokines as therapeutic agents for cardiovascular disease.
    Shibata R; Ohashi K; Murohara T; Ouchi N
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):483-7. PubMed ID: 25066649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between Selected Adipokines and Musculoskeletal and Cardiovascular Systems: A Review of Current Knowledge.
    Sierawska O; Sawczuk M
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis.
    Spiroglou SG; Kostopoulos CG; Varakis JN; Papadaki HH
    J Atheroscler Thromb; 2010 Feb; 17(2):115-30. PubMed ID: 20145358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.
    Jung HN; Jung CH
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders.
    Chung HS; Choi KM
    Curr Med Chem; 2018; 25(20):2401-2415. PubMed ID: 29210643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines and cardiovascular disease: A comprehensive review.
    Smekal A; Vaclavik J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):31-40. PubMed ID: 28228651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue, obesity and adipokines: role in cancer promotion.
    Booth A; Magnuson A; Fouts J; Foster M
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):57-74. PubMed ID: 25781552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.
    Fuster JJ; Ouchi N; Gokce N; Walsh K
    Circ Res; 2016 May; 118(11):1786-807. PubMed ID: 27230642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adipokines in systemic sclerosis: a missing link?
    Żółkiewicz J; Stochmal A; Rudnicka L
    Arch Dermatol Res; 2019 May; 311(4):251-263. PubMed ID: 30806766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue: the new endocrine organ? A review article.
    Wozniak SE; Gee LL; Wachtel MS; Frezza EE
    Dig Dis Sci; 2009 Sep; 54(9):1847-56. PubMed ID: 19052866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines expression profiles in both plasma and peri renal adipose tissue in Large White and Meishan sows: A possible involvement in the fattening and the onset of puberty.
    Barbe A; Kurowska P; Mlyczyńska E; Ramé C; Staub C; Venturi E; Billon Y; Rak A; Dupont J
    Gen Comp Endocrinol; 2020 Dec; 299():113584. PubMed ID: 32827511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.
    Gualillo O; González-Juanatey JR; Lago F
    Trends Cardiovasc Med; 2007 Nov; 17(8):275-83. PubMed ID: 18021938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel adipokines: links between obesity and atherosclerosis].
    Gauvreau D; Villeneuve N; Deshaies Y; Cianflone K
    Ann Endocrinol (Paris); 2011 Jun; 72(3):224-31. PubMed ID: 21592454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular mechanisms of obesity paradox.
    Antonopoulos AS; Tousoulis D
    Cardiovasc Res; 2017 Jul; 113(9):1074-1086. PubMed ID: 28549096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity?
    Bełtowski J
    Med Sci Monit; 2006 Jun; 12(6):RA112-9. PubMed ID: 16733497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocytokines in relation to cardiovascular disease.
    Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
    Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
    Lafontan M
    Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.